12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

October 31, 2009

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

BI 10773

DRUG

placebo

DRUG

metformin

Trial Locations (74)

Unknown

1245.9.54001 Boehringer Ingelheim Investigational Site, Capital Federal

1245.9.54002 Boehringer Ingelheim Investigational Site, Capital Federal

1245.9.54007 Boehringer Ingelheim Investigational Site, Capital Federal

1245.9.54008 Boehringer Ingelheim Investigational Site, Capital Federal

1245.9.54009 Boehringer Ingelheim Investigational Site, Capital Federal

1245.9.54010 Boehringer Ingelheim Investigational Site, Capital Federal

1245.9.54004 Boehringer Ingelheim Investigational Site, Mar del Plata

1245.9.54003 Boehringer Ingelheim Investigational Site, Mendoza

1245.9.54005 Boehringer Ingelheim Investigational Site, Salta

1245.9.54006 Boehringer Ingelheim Investigational Site, Salta

1245.9.38504 Boehringer Ingelheim Investigational Site, Karlovac

1245.9.38503 Boehringer Ingelheim Investigational Site, Krapinske Toplice

1245.9.38506 Boehringer Ingelheim Investigational Site, Osijek

1245.9.38505 Boehringer Ingelheim Investigational Site, Varaždin

1245.9.38501 Boehringer Ingelheim Investigational Site, Zagreb

1245.9.37201 Boehringer Ingelheim Investigational Site, Tallinn

1245.9.37202 Boehringer Ingelheim Investigational Site, Tallinn

1245.9.37203 Boehringer Ingelheim Investigational Site, Tallinn

1245.9.49007 Boehringer Ingelheim Investigational Site, Aschaffenburg

1245.9.49001 Boehringer Ingelheim Investigational Site, Erlangen

1245.9.49004 Boehringer Ingelheim Investigational Site, Hamburg

1245.9.49005 Boehringer Ingelheim Investigational Site, Hamburg

1245.9.49002 Boehringer Ingelheim Investigational Site, Melsungen

1245.9.49008 Boehringer Ingelheim Investigational Site, Nuremberg

1245.9.49003 Boehringer Ingelheim Investigational Site, Saint Ingbert/Oberwürzbach

1245.9.49006 Boehringer Ingelheim Investigational Site, Sulzbach-Rosenberg

1245.9.39006 Boehringer Ingelheim Investigational Site, Genova

1245.9.39001 Boehringer Ingelheim Investigational Site, Pisa

1245.9.39003 Boehringer Ingelheim Investigational Site, Pisa

1245.9.39004 Boehringer Ingelheim Investigational Site, Siena

1245.9.39005 Boehringer Ingelheim Investigational Site, Treviso

1245.9.37002 Boehringer Ingelheim Investigational Site, Klaipėda

1245.9.37001 Boehringer Ingelheim Investigational Site, Vilnius

1245.9.40003 Boehringer Ingelheim Investigational Site, Brasov

1245.9.40002 Boehringer Ingelheim Investigational Site, Bucharest

1245.9.40004 Boehringer Ingelheim Investigational Site, Galati

1245.9.40005 Boehringer Ingelheim Investigational Site, Târgu Mureş

1245.9.70002 Boehringer Ingelheim Investigational Site, Kazan'

1245.9.70003 Boehringer Ingelheim Investigational Site, Nizhny Novgorod

1245.9.70004 Boehringer Ingelheim Investigational Site, Petrozavodsk

1245.9.70005 Boehringer Ingelheim Investigational Site, Smolensk

1245.9.70006 Boehringer Ingelheim Investigational Site, Yaroslavl

1245.9.70007 Boehringer Ingelheim Investigational Site, Yaroslavl

1245.9.70001 Boehringer Ingelheim Investigational Site, Yekaterinburg

1245.9.62002 Boehringer Ingelheim Investigational Site, Bratislava

1245.9.62003 Boehringer Ingelheim Investigational Site, Lučenec

1245.9.62004 Boehringer Ingelheim Investigational Site, Nové Mesto nad Váhom

1245.9.62001 Boehringer Ingelheim Investigational Site, Prievidza

1245.9.82006 Boehringer Ingelheim Investigational Site, Goyang

1245.9.82008 Boehringer Ingelheim Investigational Site, Goyang

1245.9.82007 Boehringer Ingelheim Investigational Site, Incheon

1245.9.82002 Boehringer Ingelheim Investigational Site, Pucheon

1245.9.82001 Boehringer Ingelheim Investigational Site, Seoul

1245.9.82004 Boehringer Ingelheim Investigational Site, Seoul

1245.9.82005 Boehringer Ingelheim Investigational Site, Seoul

1245.9.82009 Boehringer Ingelheim Investigational Site, Suwon

1245.9.82003 Boehringer Ingelheim Investigational Site, Uijeongbu-si

1245.9.46003 Boehringer Ingelheim Investigational Site, Gothenburg

1245.9.46004 Boehringer Ingelheim Investigational Site, Härnösand

1245.9.46005 Boehringer Ingelheim Investigational Site, Lund

1245.9.46001 Boehringer Ingelheim Investigational Site, Stockholm

1245.9.46002 Boehringer Ingelheim Investigational Site, Västerås

1245.9.88605 Boehringer Ingelheim Investigational Site, Changhua

1245.9.88607 Boehringer Ingelheim Investigational Site, Kaohsiung City

1245.9.88604 Boehringer Ingelheim Investigational Site, Taichung

1245.9.88606 Boehringer Ingelheim Investigational Site, Tainan City

1245.9.88601 Boehringer Ingelheim Investigational Site, Taipei

1245.9.88603 Boehringer Ingelheim Investigational Site, Taipei

1245.9.88602 Boehringer Ingelheim Investigational Site, Taoyuan District

1245.9.38003 Boehringer Ingelheim Investigational Site, Kharkiv

1245.9.38004 Boehringer Ingelheim Investigational Site, Kiev

1245.9.38002 Boehringer Ingelheim Investigational Site, Odesa

1245.9.38001 Boehringer Ingelheim Investigational Site, Vinnytsia

1245.9.38005 Boehringer Ingelheim Investigational Site, Vinnytsia

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY